The DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Advances in nanomaterial-based targeted drug delivery systems
Open accessAbstract
Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and biological properties. By combining therapeutic drugs with nanoparticles using rational targeting pathways, nano-targeted delivery systems were created to overcome the main drawbacks of conventional drug treatment, including insufficient stability and solubility, lack of transmembrane transport, short circulation time, and undesirable toxic effects. Herein, we reviewed the recent developments in different targeting design strategies and therapeutic approaches employing various nanomaterial-based systems. We also discussed the challenges and perspectives of smart systems in precisely targeting different intravascular and extravascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,306
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 2×
“Doxil, the first FDA-approved nanomedicine, has 100 nm and uses the stealthy polymer polyethylene glycol (PEG) for surface modification to reduce the aggregation and opsonization of plasma proteins, extending its circulating half-life in the blood (Barenholz, 2012; Suk et al., 2016).”
BackgroundMethodPEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 1×
“To achieve high targeting efficacy, the DDS must be retained in the physiological system for an appropriate time to target specific cells and tissues to release the delivery drug, avoiding its destruction by the immune system (Davis et al., 2008).”
BackgroundTumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Gimbrone, M. A., & García-Cardeña, G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306301 · Cited by 3,476
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022 · cited 1×
“The molecules expressed in inflammatory vascular endothelium, such as selectins, ICAM-1, and VCAM-1, significantly promote transendothelial extravasation, adhesion, and recruitment of circulating leukocytes to the vessel wall (Pober and Sessa, 2007; Galvani et al., 2015; Jin et al., 2018).”
BackgroundThe Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990 · cited 1×
“The binding rate between the nanoparticles and the modified molecules should also be considered to avoid side effects caused by unsuitable binding rates (Hoshyar et al., 2016; Kou et al., 2018).”
BackgroundNanoparticle biointerfacing by platelet membrane cloaking
Hu, C.-M. J., Fang, R. H., Wang, K.-C., Luk, B. T., Thamphiwatana, S., Dehaini, D., Nguyen, P., Angsantikul, P., Wen, C. H., Kroll, A. V., et al. (2015) · Nature · doi:10.1038/nature15373 · Cited by 1,789
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Fang, R. H., Hu, C.-M. J., Luk, B. T., Gao, W., Copp, J. A., Tai, Y., O’Connor, D. E., & Zhang, L. (2014) · Nano Letters · doi:10.1021/nl500618u · Cited by 1,501
Emerging functions of the EGFR in cancer
Sigismund, S., Avanzato, D., & Lanzetti, L. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12155 · Cited by 1,469
Gabizón, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., & Barenholz, Y. (1994) · PubMed · Cited by 1,382
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Therapeutic Nanoparticles and Their Targeted Delivery Applications
Yetisgin, A. A., Cetinel, S., Zuvin, M., Kosar, A., & Kutlu, O. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,080
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
Jiang, H., Hegde, S., Knolhoff, B. L., Zhu, Y., Herndon, J. M., Meyer, M. A., Nywening, T. M., Hawkins, W. G., Shapiro, I. M., Weaver, D. T., et al. (2016) · Nature Medicine · doi:10.1038/nm.4123 · Cited by 1,060
Angiocrine functions of organ-specific endothelial cells
Rafii, S., Butler, J. M., & Ding, B.-S. (2016) · Nature · doi:10.1038/nature17040 · Cited by 941
Nakashima, Y., Raines, E. W., Plump, A. S., Breslow, J. L., & Ross, R. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.5.842 · Cited by 917
Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
Zhou, Q., Shao, S., Wang, J., Xu, C., Xiang, J., Piao, Y., Zhou, Z., Yu, Q., Tang, J., Liu, X., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0485-z · Cited by 819
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 778
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 773
Clinical Translation of Nanomedicine
Min, Y., Caster, J. M., Eblan, M. J., & Wang, A. Z. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00116 · Cited by 772
Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757
Circulating Extracellular Vesicles in Human Disease
Shah, R., Patel, T., & Freedman, J. E. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1704286 · Cited by 749
Borsig, L., Wong, R., Feramisco, J., Nadeau, D. R., Varki, N. M., & Varki, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061615598 · Cited by 714
Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine
Kinnear, C., Moore, T. L., Rodriguez-Lorenzo, L., Rothen-Rutishauser, B., & Petri-Fink, A. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00194 · Cited by 672
Particle Engineering for Pulmonary Drug Delivery
Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 645
Zhi, D., Yang, T., O'Hagan, J., Zhang, S., & Donnelly, R. F. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.032 · Cited by 637
Anticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 630
Gao, C., Huang, Q., Liu, C., Kwong, C. H. T., Yue, L., Wan, J.-B., Lee, S. M. Y., & Wang, R. (2020) · Nature Communications · doi:10.1038/s41467-020-16439-7 · Cited by 630
Exploiting the folate receptor α in oncology
Scaranti, M., Cojocaru, E., Banerjee, S., & Banerji, U. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0339-5 · Cited by 593
Shear Stress–Initiated Signaling and Its Regulation of Endothelial Function
Zhou, J., Li, Y.-S., & Chien, S. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303422 · Cited by 561
Sepsis and Endothelial Permeability
Lee, W. L., & Slutsky, A. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmcibr1007320 · Cited by 516
Design of therapeutic biomaterials to control inflammation
Tu, Z., Zhong, Y., Hu, H., Shao, D., Haag, R., Schirner, M., Lee, J., Sullenger, B., & Leong, K. W. (2022) · Nature Reviews Materials · doi:10.1038/s41578-022-00426-z · Cited by 513
Chemical and physical basics of routine formaldehyde fixation
Thavarajah, R., Mudimbaimannar, V. K., Elizabeth, J., Rao, U. K., & Ranganathan, K. (2012) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.102496 · Cited by 509
Nissen, N. I., Karsdal, M., & Willumsen, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1110-6 · Cited by 489
Silverman, J. A., & Deitcher, S. R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2042-4 · Cited by 474
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 461
Biodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges
Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430
Sala, M., Diab, R., Elaissari, A., & Fessi, H. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.046 · Cited by 428
Soft erythrocyte-based bacterial microswimmers for cargo delivery
Alapan, Y., Yasa, O., Schauer, O., Giltinan, J., Tabak, A. F., Sourjik, V., & Sitti, M. (2018) · Science Robotics · doi:10.1126/scirobotics.aar4423 · Cited by 420
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Serrels, A., Lund, T., Serrels, B., Byron, A., McPherson, R. C., von Kriegsheim, A., Gómez-Cuadrado, L., Canel, M., Muir, M., Ring, J. E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.001 · Cited by 407
Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
Fan, K., Jia, X., Zhou, M., Wang, K., Conde, J., He, J., Tian, J., & Yan, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b06969 · Cited by 395
Neutrophil‐Based Drug Delivery Systems
Chu, D., Dong, X., Shi, X., Zhang, C., & Wang, Z. (2018) · Advanced Materials · doi:10.1002/adma.201706245 · Cited by 386
Poltavets, V., Kochetkova, M., Pitson, S. M., & Samuel, M. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00431 · Cited by 377
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Niu, W., Xiao, Q., Wang, X., Zhu, J., Li, J., Liang, X., Peng, Y., Wu, C., Lu, R., Pan, Y., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.0c04753 · Cited by 372
Wang, Q., Ren, Y., Mu, J., Egilmez, N. K., Zhuang, X., Deng, Z., Zhang, L., Yan, J., Miller, D., & Zhang, H.-G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3095 · Cited by 366
Biomimetic nanoparticles for inflammation targeting
Jin, K., Luo, Z., Zhang, B., & Pang, Z. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.12.002 · Cited by 359
Nanotechnology approaches for inhalation treatment of lung diseases
Kuzmov, A., & Minko, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.07.024 · Cited by 352
Recent advances in pulmonary drug delivery using large, porous inhaled particles
Edwards, D. A., Ben-Jebria, A., & Langer, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.2.379 · Cited by 341
Davies, P. F., Civelek, M., Fang, Y., & Fleming, I. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt101 · Cited by 331
Wei, X., Ying, M., Dehaini, D., Su, Y., Kroll, A. V., Zhou, J., Gao, W., Fang, R. H., Chien, S., & Zhang, L. (2018) · ACS Nano · doi:10.1021/acsnano.7b07720 · Cited by 329
Choi, K. Y., Han, H. S., Lee, E. S., Shin, J. M., Almquist, B. D., Lee, D. S., & Park, J. H. (2019) · Advanced Materials · doi:10.1002/adma.201803549 · Cited by 319
Overviews on the cellular uptake mechanism of polysaccharide colloidal nanoparticles
Salatin, S., & Yari Khosroushahi, A. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13110 · Cited by 315
Galvani, S., Sanson, M., Blaho, V. A., Swendeman, S. L., Obinata, H., Conger, H., Dahlbäck, B., Kono, M., Proia, R. L., Smith, J. D., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa2581 · Cited by 314
Wang, Y., Zhang, K., Qin, X., Li, T., Qiu, J., Yin, T., Huang, J., McGinty, S., Pontrelli, G., Ren, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201900172 · Cited by 314
Schneider, C. S., Xu, Q., Boylan, N. J., Chisholm, J., Tang, B. C., Schuster, B. S., Henning, A., Ensign, L. M., Lee, E., Adstamongkonkul, P., et al. (2017) · Science Advances · doi:10.1126/sciadv.1601556 · Cited by 311
Kou, L., Bhutia, Y. D., Yao, Q., He, Z., Sun, J., & Ganapathy, V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00027 · Cited by 308
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11719-3 · Cited by 300
Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery
Wang, H., Liu, Y., He, R., Xu, D., Zang, J., Weeranoppanant, N., Dong, H., & Li, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01392j · Cited by 297
Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
Lamson, N. G., Berger, A., Fein, K. C., & Whitehead, K. A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0465-5 · Cited by 296
Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain
Anraku, Y., Kuwahara, H., Fukusato, Y., Mizoguchi, A., Ishii, T., Nitta, K., Matsumoto, Y., Toh, K., Miyata, K., Uchida, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00952-3 · Cited by 294
Mangal, S., Gao, W., Li, T., & Zhou, Q. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.34 · Cited by 288
Ahlawat, J., Guillama Barroso, G., Masoudi Asil, S., Alvarado, M., Armendariz, I., Bernal, J., Carabaza, X., Chavez, S., Cruz, P., Escalante, V., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01592 · Cited by 274
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Couch, J. A., Yu, Y. J., Zhang, Y., Tarrant, J. M., Fuji, R. N., Meilandt, W. J., Solanoy, H., Tong, R. K., Hoyte, K., Luk, W., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005338 · Cited by 268
Johnsen, K. B., Burkhart, A., Melander, F., Kempen, P. J., Vejlebo, J. B., Siupka, P., Nielsen, M. S., Andresen, T. L., & Moos, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11220-1 · Cited by 261
Ojha, T., Pathak, V., Shi, Y., Hennink, W. E., Moonen, C. T. W., Storm, G., Kiessling, F., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.007 · Cited by 260
Duan, L., Yang, L., Jin, J., Yang, F., Liu, D., Hu, K., Wang, Q., Yue, Y., & Gu, N. (2020) · Theranostics · doi:10.7150/thno.37593 · Cited by 251
Liu, R., Xiao, W., Hu, C., Xie, R., & Gao, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.005 · Cited by 250 · cited 1×
“Hyaluronic acid binds to the CD44 receptor, upregulated in various cancer cells, which improves ECM targeting and has good therapeutic potential in some cancers (Liu et al., 2018; Choi et al., 2019; Wang X. et al., 2021).”
BackgroundBen-Akiva, E., Meyer, R. A., Yu, H., Smith, J. T., Pardoll, D. M., & Green, J. J. (2020) · Science Advances · doi:10.1126/sciadv.aay9035 · Cited by 248
Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro, R. G. R., Coutinho, A. J., Pinheiro, M., & Neves, A. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111654 · Cited by 247
Oral Delivery of Biologics for Precision Medicine
Durán‐Lobato, M., Niu, Z., & Alonso, M. J. (2020) · Advanced Materials · doi:10.1002/adma.201901935 · Cited by 246
Zhang, D., Wang, G., Yu, X., Wei, T., Farbiak, L., Johnson, L. T., Taylor, A. M., Xu, J., Hong, Y., Zhu, H., et al. (2022) · Nature Nanotechnology · doi:10.1038/s41565-022-01122-3 · Cited by 243
Li, G., Wang, S., Deng, D., Xiao, Z., Dong, Z., Wang, Z., Lei, Q., Gao, S., Huang, G., Zhang, E., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b06689 · Cited by 233
Fu, J., Li, T., Yang, Y., Jiang, L., Wang, W., Fu, L., Zhu, Y., & Hao, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120537 · Cited by 231
Ligand density on nanoparticles: A parameter with critical impact on nanomedicine
Alkilany, A. M., Zhu, L., Weller, H., Mews, A., Parak, W. J., Barz, M., & Feliu, N. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.010 · Cited by 229
Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications
Uthaman, S., Huh, K. M., & Park, I.-K. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0132-z · Cited by 227
Liu, X., Lin, P., Perrett, I., Lin, J., Liao, Y.-P., Chang, C. H., Jiang, J., Wu, N., Donahue, T., Wainberg, Z., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92284 · Cited by 222
Intracellular transport and regulation of transcytosis across the blood–brain barrier
Villaseñor, R., Lampe, J., Schwaninger, M., & Collin, L. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2982-x · Cited by 209
PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
Osman, G., Rodriguez, J., Chan, S. Y., Chisholm, J., Duncan, G., Kim, N., Tatler, A. L., Shakesheff, K. M., Hanes, J., Suk, J. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.001 · Cited by 208
Cell Membrane Coated Nanoparticles: next-generation Therapeutics
Narain, A., Asawa, S., Chhabria, V., & Patil-Sen, Y. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0225 · Cited by 207
Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy
Ren, H., He, Y., Liang, J., Cheng, Z., Zhang, M., Zhu, Y., Hong, C., Qin, J., Xu, X., & Wang, J. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b22693 · Cited by 206
Mo, J., Xie, Q., Wei, W., & Zhao, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04873-7 · Cited by 204
Self-citationSong, Y., Huang, Z., Liu, X., Pang, Z., Chen, J., Yang, H., Zhang, N., Cao, Z., Liu, M., Cao, J., et al. (2019) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2018.08.002 · Cited by 203
Tanaka, N., Kanatani, S., Tomer, R., Sahlgren, C., Kronqvist, P., Kaczynska, D., Louhivuori, L., Kis, L., Lindh, C., Mitura, P., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0139-0 · Cited by 202
Development of Novel Therapeutics Targeting the Blood–Brain Barrier: From Barrier to Carrier
Li, J., Zheng, M., Shimoni, O., Banks, W. A., Bush, A. I., Gamble, J. R., & Shi, B. (2021) · Advanced Science · doi:10.1002/advs.202101090 · Cited by 202
Lapteva, M., Mondon, K., Möller, M., Gurny, R., & Kalia, Y. N. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400639e · Cited by 194
Endothelium in health and disease.
Aird, W. C. (2008) · PubMed · Cited by 192
Gros, A., Syvannarath, V., Lamrani, L., Ollivier, V., Loyau, S., Goerge, T., Nieswandt, B., Jandrot-Perrus, M., & Ho-Tin-Noé, B. (2015) · Blood · doi:10.1182/blood-2014-12-617159 · Cited by 188
Bai, X., Zhao, G., Chen, Q., Li, Z., Gao, M., Ho, W., Xu, X., & Zhang, X.-Q. (2022) · Science Advances · doi:10.1126/sciadv.abn7162 · Cited by 187
Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation
Boada, C., Zinger, A., Tsao, C., Zhao, P., Martinez, J. O., Hartman, K., Naoi, T., Sukhovershin, R., Sushnitha, M., Molinaro, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315185 · Cited by 186
Active transcytosis and new opportunities for cancer nanomedicine
Pandit, S., Dutta, D., & Nie, S. (2020) · Nature Materials · doi:10.1038/s41563-020-0672-1 · Cited by 181
Cell membrane-formed nanovesicles for disease-targeted delivery
Gao, J., Chu, D., & Wang, Z. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.024 · Cited by 179
Engineered three-dimensional scaffolds for enhanced bone regeneration in osteonecrosis
Zhu, T., Cui, Y., Zhang, M., Zhao, D., Liu, G., & Ding, J. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.04.008 · Cited by 178
Targeting cartilage EGFR pathway for osteoarthritis treatment
Wei, Y., Luo, L., Gui, T., Yu, F., Yan, L., Yao, L., Zhong, L., Yu, W., Han, B., Patel, J. M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3946 · Cited by 178
Zhong, Y., Zhang, Y., Xu, J., Zhou, J., Liu, J., Ye, M., Zhang, L., Qiao, B., Wang, Z.-G., Ran, H.-T., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b09277 · Cited by 177
Zhang, D. Y., Dmello, C., Chen, L., Arrieta, V. A., Gonzalez-Buendia, E., Kane, J. R., Magnusson, L. P., Baran, A., James, C. D., Horbinski, C., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2182 · Cited by 176
Zhu, Z., Zhai, Y., Hao, Y., Wang, Q., Han, F., Zheng, W., Hong, J., Cui, L., Jin, W., Ma, S., et al. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12255 · Cited by 175
Gupta, S., Kesarla, R., Chotai, N., Misra, A., & Omri, A. (2017) · BioMed Research International · doi:10.1155/2017/5984014 · Cited by 172
Li, S., Zhang, Y., Wang, J., Zhao, Y., Ji, T., Zhao, X., Ding, Y., Zhao, X., Zhao, R., Li, F., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0115-8 · Cited by 171
Shim, M. K., Park, J., Yoon, H. Y., Lee, S., Um, W., Kim, J.-H., Kang, S.-W., Seo, J.-W., Hyun, S.-W., Park, J. H., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.11.032 · Cited by 169
Ge, C., Yang, J., Duan, S., Liu, Y., Meng, F., & Yin, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04957 · Cited by 163
Johnsen, K. B., Bak, M., Kempen, P. J., Melander, F., Burkhart, A., Thomsen, M. S., Nielsen, M. S., Moos, T., & Andresen, T. L. (2018) · Theranostics · doi:10.7150/thno.25228 · Cited by 162
Johnsen, K. B., Bak, M., Melander, F., Thomsen, M. S., Burkhart, A., Kempen, P. J., Andresen, T. L., & Moos, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.005 · Cited by 162
Rosière, R., Van Woensel, M., Gelbcke, M., Mathieu, V., Hecq, J., Mathivet, T., Vermeersch, M., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00846 · Cited by 161
Tabatabaei, S. N., Girouard, H., Carret, A., & Martel, S. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.027 · Cited by 160
Bedingfield, S. K., Colazo, J. M., Yu, F. Z., Liu, D. D., Jackson, M. A., Himmel, L. E., Cho, H., Crofford, L. J., Hasty, K. A., & Duvall, C. L. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00780-3 · Cited by 159
Doherty, G. J., Tempero, M. A., & Corrie, P. G. (2017) · Future Oncology · doi:10.2217/fon-2017-0338 · Cited by 158
Shen, M., Liu, T., Yu, T.-W., Kv, R., Chiang, W., Tsai, Y.-C., Chen, H., Lin, S., & Chiu, H. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.019 · Cited by 156
Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment
Kang, L., Yoon, J., Rho, J. G., Han, H. S., Lee, S., Oh, Y. S., Kim, I. H., Kim, E., Kim, S. J., Lim, Y. T., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120967 · Cited by 156
Li, S., Zhang, Y., Ho, S., Li, B., Wang, M., Deng, X., Yang, N., Liu, G., Lu, Z., Xu, J., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0573-2 · Cited by 155
Lee, S., Han, H., Koo, H., Na, J. H., Yoon, H. Y., Lee, K. E., Lee, H., Kim, H., Kwon, I. C., & Kim, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.035 · Cited by 154
Zhou, Y., Chen, Z., Zhao, D., Li, D., He, C., & Chen, X. (2021) · Advanced Materials · doi:10.1002/adma.202102044 · Cited by 153
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
Jahan, S. T., Sadat, S. M. A., Walliser, M., & Haddadi, A. (2017) · Journal of Drug Delivery · doi:10.1155/2017/9090325 · Cited by 152
Nanomedicine progress in thrombolytic therapy
Zenych, A., Fournier, L., & Chauvierre, C. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120297 · Cited by 151
Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150 · cited 1×
“As an adjunct to cancer treatment, heat therapy (HT) has a synergistic effect on chemotherapy and radiotherapy (Dunne et al., 2020).”
BackgroundVemula, S., Shi, J., Hanneman, P., Wei, L., & Kapur, R. (2009) · Blood · doi:10.1182/blood-2009-08-237222 · Cited by 150
The proprotein convertase furin in tumour progression
Jaaks, P., & Bernasconi, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.30714 · Cited by 148
Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy
Kunde, S. S., & Wairkar, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120395 · Cited by 145
Sudhakar, S., Chandran, S. V., Selvamurugan, N., & Nazeer, R. A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.079 · Cited by 144
Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites
Dong, X., Chu, D., & Wang, Z. (2017) · Theranostics · doi:10.7150/thno.18069 · Cited by 141
Lundy, D. J., Chen, K.-H., Toh, E. K.-W., & Hsieh, P. C. H. (2016) · Scientific Reports · doi:10.1038/srep25613 · Cited by 137
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Yhee, J. Y., Im, J., & Nho, R. S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5090082 · Cited by 135
Targeted treatment for osteoarthritis: drugs and delivery system
Mao, L., Wu, W., Wang, M., Guo, J., Li, H., Zhang, S., Xu, J., & Zou, J. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1971798 · Cited by 134
Soe, Z. C., Kwon, J. B., Thapa, R. K., Ou, W., Nguyen, H. T., Gautam, M., Oh, K. T., Choi, H., Ku, S., Yong, C. S., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020063 · Cited by 130
Chen, D., Liu, J., Wu, J., & Suk, J. S. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1854222 · Cited by 129
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery
Shen, A. M., & Minko, T. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.011 · Cited by 128
Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy
Zhao, Y., Xie, R., Yodsanit, N., Ye, M., Wang, Y., & Gong, S. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100986 · Cited by 128
Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
Molinaro, R., Evangelopoulos, M., Hoffman, J., Corbo, C., Taraballi, F., Martinez, J. O., Hartman, K. A., Cosco, D., Costa, G., Romeo, I., et al. (2018) · Advances in Materials · doi:10.1002/adma.201702749 · Cited by 126
Martinez, J. O., Molinaro, R., Hartman, K. A., Boada, C., Sukhovershin, R. A., Rosa, E. D., Kuri, D., Zhang, S., Evangelopoulos, M., Carter, A. M., et al. (2018) · Theranostics · doi:10.7150/thno.22078 · Cited by 122
Delivery of Nanoparticle-Based Radiosensitizers for Radiotherapy Applications
Boateng, F., & Ngwa, W. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010273 · Cited by 122
Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery
Nag, O. K., & Delehanty, J. B. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11100543 · Cited by 121
Physical triggering strategies for drug delivery
Sun, T., Dasgupta, A., Zhao, Z., Nurunnabi, M., & Mitragotri, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.010 · Cited by 120
Chen, L., Zhou, Z., Hu, C., Maitz, M. F., Yang, L., Luo, R., & Wang, Y. (2022) · Research · doi:10.34133/2022/9845459 · Cited by 117
Modulation of Immune Response Using Engineered Nanoparticle Surfaces
Moyano, D. F., Liu, Y., Peer, D., & Rotello, V. M. (2015) · Small · doi:10.1002/smll.201502273 · Cited by 107
Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA
Chen, M., Chen, M., & He, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1608219 · Cited by 107
Hong, S., Zheng, D., Zhang, C., Huang, Q., Cheng, S., & Zhang, X. (2020) · Science Advances · doi:10.1126/sciadv.abb0020 · Cited by 107
The pericellular hyaluronan of articular chondrocytes
Knudson, W., Ishizuka, S., Terabe, K., Askew, E. B., & Knudson, C. B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.005 · Cited by 106
Dhaliwal, A. K., & Zheng, G. (2019) · Theranostics · doi:10.7150/thno.37204 · Cited by 106
Ta, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P., & Peter, K. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1316262 · Cited by 105
Li, X., Vemireddy, V., Cai, Q., Xiong, H., Kang, P., Li, X., Giannotta, M., Hayenga, H. N., Pan, E., Sirsi, S. R., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c02996 · Cited by 105
Surface chemistry governs cellular tropism of nanoparticles in the brain
Song, E., Gaudin, A., King, A. R., Seo, Y.-E., Suh, H., Deng, Y., Cui, J., Tietjen, G. T., Huttner, A. J., & Saltzman, W. M. (2017) · Nature Communications · doi:10.1038/ncomms15322 · Cited by 103
Wang, H., Ding, T., Guan, J., Liu, X., Wang, J., Jin, P., Hou, S., Lu, W., Qian, J., Wang, W., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02821 · Cited by 103
Abumanhal-Masarweh, H., Koren, L., Zinger, A., Yaari, Z. A., Krinsky, N., Kaneti, G., Dahan, N., Lupu-Haber, Y., Suss-Toby, E., Weiss‐Messer, E., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.004 · Cited by 100
Song, Y., Li, D., Lü, Y., Jiang, K., Yang, Y., Xu, Y., Dong, L., Yan, X., Ling, D., Yang, X., et al. (2020) · National Science Review · doi:10.1093/nsr/nwz201 · Cited by 99
Lapin, N. A., Gill, K., Shah, B., & Chopra, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-73312-9 · Cited by 99
Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease
Li, D., Yang, M., Xu, H., Zhu, M., Zhang, Y., Tian, C., Nie, Y., Wang, J., Liang, Y., Yao, J., et al. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb01190e · Cited by 98
Oral delivery of metformin by chitosan nanoparticles for polycystic kidney disease
Wang, J., Chin, D. D., Poon, C. J., Mancino, V., Pham, J., Li, H., Ho, P., Hallows, K. R., & Chung, E. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.047 · Cited by 97
Yokoi, K., Kojic, M., Milosevic, M., Tanei, T., Ferrari, M., & Ziemys, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3494 · Cited by 95
Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study
Djokić, M., Čemažar, M., Popovič, P., Kos, B., Dežman, R., Bošnjak, M., Žakelj, M. N., Damijan Miklavčič, A., Potrč, S., Štabuc, B., et al. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.01.090 · Cited by 94
Zhang, X., Jin, H., Huang, X., Chaurasiya, B., Dong, D., Shanley, T. P., & Zhao, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110196 · Cited by 93
Mechanotransduction at focal adhesions: from physiology to cancer development
Seong, J., Wang, N., & Wang, Y. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12045 · Cited by 90
Wu, G., Wei, W., Zhang, J., Nie, W., Yuan, L., Huang, Y., Zuo, L., Huang, L., Xi, X., & Xie, H. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119963 · Cited by 90
Xie, R., Ruan, S., Liu, J., Qin, L., Yang, C., Tong, F., Lei, T., Shevtsov, M. A., Gao, H., & Qin, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120891 · Cited by 90
Microstructural alterations of sputum in cystic fibrosis lung disease
Duncan, G. A., Jung, J., Joseph, A., Thaxton, A., West, N. E., Boyle, M., Hanes, J. S., & Suk, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.88198 · Cited by 89
Azevedo, C., Nilsen, J., Grevys, A., Nunes, R., Andersen, J. T., & Sarmento, B. F. C. C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.005 · Cited by 89
Tumor vascular infarction: prospects and challenges
Jahanban-Esfahlan, R., Seidi, K., & Zarghami, N. (2017) · International Journal of Hematology · doi:10.1007/s12185-016-2171-3 · Cited by 88
Self-Assembled Colloidal Gel Using Cell Membrane-Coated Nanosponges as Building Blocks
Zhang, Y., Gao, W., Chen, Y., Escajadillo, T., Ungerleider, J. L., Fang, R. H., Christman, K. L., Nizet, V., & Zhang, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b06968 · Cited by 88
Improved i.p. drug delivery with bioadhesive nanoparticles
Deng, Y., Yang, F., Cocco, E., Song, E., Zhang, J., Cui, J., Mohideen, M., Bellone, S., Santin, A. D., & Saltzman, W. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523141113 · Cited by 87
Gao, X., Zhang, J., Huang, Z., Zuo, T., Lu, Q., Wu, G., & Shen, Q. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b05119 · Cited by 87
Extracellular vesicles as new pharmacological targets to treat atherosclerosis
Yin, M., Loyer, X., & Boulanger, C. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.047 · Cited by 86
Enhancing Inflammation Targeting Using Tunable Leukocyte-Based Biomimetic Nanoparticles
Zinger, A., Sushnitha, M., Naoi, T., Baudo, G., Rosa, E. D., Chang, J. C., Tasciotti, E., & Taraballi, F. (2021) · ACS Nano · doi:10.1021/acsnano.0c05792 · Cited by 86
Zhang, G., Wang, Q., Tao, W., Jiang, W., Elinav, E., Wang, Y., & Zhu, S. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00903-4 · Cited by 86
PBCA-based polymeric microbubbles for molecular imaging and drug delivery
Koczera, P., Appold, L., Shi, Y., Liu, M., Dasgupta, A., Pathak, V., Ojha, T., Fokong, S., Wu, Z., van Zandvoort, M., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.006 · Cited by 85
Blocking neutrophil diapedesis prevents hemorrhage during thrombocytopenia
Hillgruber, C., Pöppelmann, B., Weishaupt, C., Steingräber, A. K., Wessel, F., Berdel, W. E., Gessner, J. E., Ho‐Tin‐Noé, B., Vestweber, D., & Goerge, T. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142076 · Cited by 85
Yao, J., Yang, Z., Huang, L., Yang, C., Wang, J., Cao, Y., Hao, L., Zhang, L., Zhang, J., Li, P., et al. (2021) · Advanced Science · doi:10.1002/advs.202100850 · Cited by 84
Self-citationInfante, J. R., Korn, R. L., Rosen, L. S., LoRusso, P., Dychter, S. S., Zhu, J., Maneval, D. C., Jiang, P., Shepard, H. M., Frost, G., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.327 · Cited by 83
Regulation of endothelial cell permeability by platelet-derived extracellular vesicles
Miyazawa, B. Y., Trivedi, A. A., Togarrati, P. P., Potter, D. R., Baimukanova, G., Vivona, L. R., Lin, M., Lopez, E., Callcut, R. A., Srivastava, A. K., et al. (2019) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000002230 · Cited by 82
Lin, C., Tong, F., Liu, R., Xie, R., Lei, T., Chen, Y., Yang, Z., Gao, H., & Yu, X. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.009 · Cited by 82
Paris, J. L., Villaverde, G., Gómez‐Graña, S., & Vallet‐Regí, M. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.004 · Cited by 81
Dosta, P., Tamargo, I. A., Ramos, V., Kumar, S., Kang, D. W., Borrós, S., & Jo, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001894 · Cited by 77
Leo, V. D., Ruscigno, S., Trapani, A., Gioia, S. D., Milano, F., Mandracchia, D., Comparelli, R., Castellani, S., Agostiano, A., Trapani, G., et al. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.04.030 · Cited by 75
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
Choudhari, M., Hejmady, S., Narayan Saha, R., Damle, S., Singhvi, G., Alexander, A., Kesharwani, P., & Kumar Dubey, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120351 · Cited by 74
Zhong, Q., Merkel, O. M., Reineke, J., & da Rocha, S. R. P. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00036 · Cited by 74
Arias, S. L., Shetty, A. R., Devorkin, J., & Allain, J. P. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.013 · Cited by 73
Kim, Y., Uthaman, S., Pillarisetti, S., Noh, K., Huh, K. M., & Park, I. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.03.027 · Cited by 73
Wang, S., Shin, I. S., Hancock, H. A., Jang, B., Kim, H.-S., Lee, S. M., Zderic, V., Frenkel, V., Pastan, I. H., Paik, C. H., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.025 · Cited by 72
Toxicological assessment of nanoparticle interactions with the pulmonary system
Osman, N., Sexton, D. W., & Saleem, I. Y. (2019) · Nanotoxicology · doi:10.1080/17435390.2019.1661043 · Cited by 70
Zhang, X., Detering, L., Sultan, D. H., Luehmann, H. P., Li, L., Heo, G. S., Zhang, X., Lou, L., Grierson, P. M., Greco, S., et al. (2021) · ACS Nano · doi:10.1021/acsnano.0c08185 · Cited by 70
Mohideen, M., Quijano, E., Song, E., Deng, Y., Panse, G., Zhang, W., Clark, M. R., & Saltzman, W. M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.029 · Cited by 69
Gao, W. Z., Li, X., Liu, Z., Fu, W., Sun, Y., Cao, W., Tong, L., & Tang, B. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04912 · Cited by 67
Self-citation
Cited by
Rodrigues, A. S., Batista, J. G. S., Rodrigues, M. Á. V., Thipe, V. C., Minarini, L. A. R., Lopes, P. S., & Lugão, A. B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1440065 · Cited by 346
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Advances in Chitosan-Based Smart Hydrogels for Colorectal Cancer Treatment
Piotrowska, U., & Orzechowska, K. (2024) · Pharmaceuticals · doi:10.3390/ph17101260 · Cited by 30
Maharaja Agrasen Himalayan Garhwal University, P., Kumar, P., Goel, A., Maharaja Agrasen Himalayan Garhwal University, P., Dash, B., Amity Institute of Pharmacy, A. U., Rishishwar, P., Maharaja Agrasen Himalayan Garhwal University, P., S, J., Alpha Pharma Industries, K. 2., et al. (2025) · Chinese Journal of Applied Physiology · doi:10.62958/j.cjap.2025.001 · Cited by 6
Metadata
- Authors
- Cheng, X., Xie, Q., & Sun, Y.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-04-13
- Volume
- 11
- Pages
- 1177151-1177151
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W4365449016
- Cited by
- 395
- References
- 269
- FWCI
- 21.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.